Western Central Europe

How London’s first dedicated HIV ward changed the AIDS response

03 October 2019

Opened in 1987 by Princess Diana, the Broderip Ward at the Middlesex Hospital in London was the United Kingdom’s first ward dedicated to caring for HIV patients. UNAIDS Senior Adviser on Science, Peter Godfrey-Faussett, worked on the Broderip Ward as a newly qualified doctor and remembers it as an intense and highly emotional period.

 

What are your first memories of HIV?

I was finishing my medical training in London when the first reports of what would subsequently be called HIV and AIDS came out. We had no idea then of the unprecedented nature of what was happening. As a medical student approaching my final exams, my concern was to know the facts, but it was clear to me even then that many of these “facts” were not yet understood. After qualifying, I soon found myself working at the Hospital for Tropical Diseases in London and on the Broderip Ward at the Middlesex Hospital.

 

How did London’s medical professionals react to this new health challenge?

The organization of services for HIV varied in different parts of London. The staff at the sexual health clinics, or departments of genitourinary medicine, as they were called then, were establishing outpatient services with counselling, support and care for people living with HIV. But these teams were generally not well equipped to provide care for people who had to be admitted to hospital. In each hospital, a different specialist team took on the care of the ever-expanding population of people living with, and dying from, HIV. Many of those needing care had pneumonia, often caused by pneumocystis. Others had persistent severe diarrhoea, neurological problems or skin diseases, including Kaposi's sarcoma.

We had an amazing team led by Steve Semple and worked in close collaboration with the staff at James Pringle House, one of the dedicated sexual health clinics in London. Steve Semple was a respiratory physician with an expertise in the normal regulation of breathing. In other parts of London, the leaders were gastroenterologists, immunologists or infectious disease physicians.

We were all learning quickly how best to care for a wider range of infections, cancers and other conditions, all while coming to understand the social networks and behaviours of our mostly gay patients.

 

It must have been a difficult time

It was, of course, a hugely sad time. We could treat many opportunistic infections and provide counselling and support, but HIV was almost invariably lethal in those days and we saw so many young men, who were often at the forefront of the lively and creative communities that made London such a great city, fade away gradually or deteriorate more suddenly and die.

As a medical student and young doctor, most of the people that I had treated were reaching the end of full productive lives, but here on the Broderip Ward were people of my own age, reading the same books, going to the same operas and plays. It was often hard to remain clinically detached. I can remember so many of them so clearly. And so many of their loved ones and families.

 

How did the opening of the Broderip Ward change the way people were cared for?

The nurse in charge of the ward, Jacqui Elliott, was a wonderful woman. Along with Steve Semple, she encouraged us all to break the mould and provide care in a very different way. Back then, hospitals were quite old fashioned and regimented. The matron and the consultant were at the point of a huge pyramid, and often the patients were near the bottom!

Right from the start we engaged with the patients and their partners, and, where necessary, turned a blind eye to regulations. The ward was the only one in the hospital to have additional fridges full of delicious meals that people brought in for their partners, often shared with other patients and the health team!  

In those days, there were payphone kiosks at the end of long cold corridors in the hospital and hospital gowns were hideous affairs that tied up loosely at the back. We were the first ward to install a phone on the nurses’ desk so that patients could make calls more easily. We encouraged people to wear their own clothes and dressing gowns and to come and go from the ward as they wished. Everyone on Broderip worked around the clock. Our parties were the ones that everyone in the hospital wanted to come to.

We were learning, and no doubt we made mistakes, but we were certainly among the first medical professionals to listen to our patients and to try to provide what they needed.

 

And did clinical care change?

The dedicated ward was quickly a focus for teams from all over the teaching hospital. Whenever something new or strange occurred, we had a network of the best specialists in every medical discipline. The weekly clinical meeting attracted clinicians from all over the hospital and from the other hospitals in London and elsewhere.

As a junior doctor it was terrifying having to present each complicated patient to the assembled experts and seek their inputs. But I think the medical care that our patients received was at the cutting edge. We had strong relationships with the psychosocial counselling teams and with the palliative care team, who worked hard to make dying as comfortable as possible. We were, of course, trying out new antiretroviral medicines. Many of our patients were in the early trials of zidovudine, and some patients did improve. 

 

How did patients, their friends and families and staff on the ward cope?

Each patient was an individual with his (or occasionally her) particular relationships with friends, lovers and family. For some, however, admission to the Broderip Ward was the first time that people had acknowledged their sexuality within their family, and they were also having to deal with coming to terms with HIV and the implications of impending death. The staff on the ward had to be constantly aware of who knew what and who could meet whom. Some patients preferred their family not to know on which ward they were being cared for. One of our jobs on the ward was to facilitate disclosure and counsel patients and their partners and families as they came to terms with their situation. We also had a team of make-up artists to help camouflage the visible signs of Kaposi’s sarcoma and dieticians who aimed to optimize people’s nutrition. There was always a strong sense of camaraderie and plenty of opportunities for laughter as well as tears.

 

How did the United Kingdom’s approach to HIV change in the 1990s and beyond?

The arrival of increasingly effective antiretroviral therapies changed everything. Early treatments were toxic and hard to manage, with specific needs for some pills with food, some without, some needing to be kept in the fridge and some needing an alarm clock to take in the middle of the night. But they worked.

Patients in hospital began to realize that they were not going to die in the next year or two. The United Kingdom’s amazing health system, the National Health Service (NHS), and the wide network of sexual health clinics, meant that professional, high-quality care and treatment was accessible to everyone at no cost. London has always been a centre for travel and migration and the diagnosis and treatment of sexually transmitted infections were exempt from any questions about residence or immigration status. Even for hospital care, the rules could be interpreted to allow everyone to be treated.

The other huge development was that grass-root community organizations sprung up and were funded. People among the African diaspora supported each other and became more organized and vocal. Services in different parts of London catered to different population bases, so that in our hospital many of our patients were gay men, whereas in east London there was a much larger population of women, usually African. Inevitably, people's challenges reflected the social context in which they lived, as well as the gender-specific clinical aspects of HIV.

More recently, some of the systems that made the United Kingdom so open to people living with HIV have changed. Funding for the sexual health clinics and community organizations is tighter, and the restrictions on who is eligible for NHS treatment are enforced more rigorously. On the other hand, most United Kingdom cities remain vibrant, tolerant places and the gay community especially has pushed for earlier and better diagnosis, treatment and prevention. Stigma is certainly still there, but I believe most people can find a clinic and a team that welcomes and supports them through the challenges of living with HIV.

 

There is such an array of treatment and prevention options available today, is the HIV epidemic over in the United Kingdom?

We are making exciting progress, and each year sees a fall in the number of new HIV infections, particularly in London and the other big cities. Outbreaks will continue, recently among people who inject drugs in Scotland. Ongoing stigma and denial prevent people from all communities, and particularity the African diaspora, from getting tested and accessing effective treatment or prevention promptly.

And, of course, people need treatment for life. So even as the number of new infections falls, we will need ongoing care and support and good surveillance for many more years.

UNAIDS saddened by the death of Jacques Chirac

26 September 2019

GENEVA, 26 September 2019—UNAIDS is deeply saddened by the death of the former President of France, Jacques Chirac, an early champion of the AIDS response.

Speaking in 1997 at the opening ceremony of the International Conference on AIDS in Africa (ICASA) in Abidjan, Côte d’Ivoire, he denounced a response to HIV that was on two tracks, where HIV treatment was only available in the Global North but people living with HIV were disproportionally living in the Global South.

In 1997, he announced the creation of the International Therapeutic Solidarity Fund, which funded access to antiretroviral therapy, including in the least developed countries. The fund was a precursor to the establishment in 2002 of the Global Fund to Fight AIDS, Tuberculosis and Malaria. In 2006, Mr Chirac established the solidarity tax on aeroplane tickets, dubbed the Chirac Tax, which today is still an important source of financing for the AIDS response.

In 2008, after leaving the Presidency, he established the Fondation Chirac, which continues to work for access to health and quality medicines globally.

“It is thanks to leaders such as Jacques Chirac, who took responsibility and acted with principle, that today more than 23 million people globally have access to HIV treatment. I pay tribute to Mr Chirac’s leadership,” said Gunilla Carlsson, UNAIDS Executive Director, a.i.

UNAIDS

The Joint United Nations Programme on HIV/AIDS (UNAIDS) leads and inspires the world to achieve its shared vision of zero new HIV infections, zero discrimination and zero AIDS-related deaths. UNAIDS unites the efforts of 11 UN organizations—UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, UN Women, ILO, UNESCO, WHO and the World Bank—and works closely with global and national partners towards ending the AIDS epidemic by 2030 as part of the Sustainable Development Goals. Learn more at unaids.org and connect with us on Facebook, Twitter, Instagram and YouTube.

Contact

UNAIDS Geneva
Anne-Claire Guichard
tel. +41 22 791 2321
guicharda@unaids.org

Contact

UNAIDS Media
tel. +41 22 791 42 37
communications@unaids.org

Interview with UNAIDS PrEP expert Rosalind Coleman

16 September 2019

Pre-exposure prophylaxis (PrEP) is delivered by a pill made of a combination of medicines. It has proved to be highly effective in preventing HIV-negative people from acquiring the virus. It is being rolled out or piloted in many countries across the world, including the United Kingdom. UNAIDS PrEP expert Rosalind Coleman explains.

How does the United Kingdom’s roll-out of PrEP compare with that of other high-income countries?

The United Kingdom’s PrEP programme is the largest in Europe, in terms of the number of people who have started PrEP. But the variety of ways that PrEP is made available in the country illustrates clearly that one PrEP strategy does not fit all countries. It also demonstrates how important advocates are and the key role of collaboration between all parties interested in PrEP.

In Scotland, PrEP is available free in sexual health clinics to residents of Scotland. The national-level purchasers have successfully negotiated an affordable price for them to buy PrEP.

In England, PrEP is not available routinely and advocates, progressive PrEP providers and others who support PrEP provision have had to be resourceful. Generic medicines have been purchased at competitive prices through the establishment of a large research trial that makes PrEP available in sexual health clinics. But the trial has not been able to provide PrEP to all the people who are asking for it, so online purchasing of PrEP from overseas is also a large source of PrEP. For people buying online, access to the clinical support, tests and follow-up that are part and parcel of a quality PrEP service should be provided and promoted.

 

 

Can you tell us a little more about the roll-out of PrEP in low- and middle-income countries?

The roll-out of PrEP in low- and middle-income countries is a mixed picture. Great progress has been made in providing PrEP in southern and eastern Africa and in some other regions, such as Thailand and now Viet Nam in Asia, and Brazil in Latin America. In other countries, particularly those with a growing HIV epidemic, PrEP access is extremely difficult. There is a combination of reasons for the low PrEP provision: the cost of the programme and overall low attention to primary HIV prevention certainly play a role, as does stigma and discrimination against providing appropriate services for many of the key populations that could benefit. Insufficient knowledge of PrEP and even misinformation among potential users and PrEP providers also prevent the promotion of PrEP.

Very clear and focused planning for PrEP scale-up, as part of a comprehensive HIV prevention programme, is an essential part of reducing new HIV infections

 

The use of PrEP is often associated with key populations, such as sex workers or gay men and other men who have sex with men, but can it be useful in other contexts? 

For a PrEP programme to be effective, PrEP has to be taken by people with a real likelihood of contracting HIV and who want to take control of reducing that possibility―often members of key populations, but anyone in the situation of having a high prospect of HIV exposure should be able to discuss the use of PrEP and access it. This could include the HIV-negative member of a serodiscordant couple before the person living with HIV reaches viral suppression, or someone with a previous diagnosis of a sexually transmitted infection (STI) where there is a high rate of untreated HIV among their sexual partners.

Remaining on PrEP while in a period of potential high HIV exposure is vital and similarly depends on a personal conviction to take PrEP, good understanding of how to use and stop PrEP and ease of access.

How PrEP is messaged―this should be in a non-stigmatizing and empowering way from public advertising to health-care worker attitude―will make all the difference in effective PrEP uptake and continuation.

 

There has been some questioning of PrEP as contributing to the increase in STIs such as syphilis and gonorrhoea. Is there any evidence for this?

The link between PrEP use and increase in other STIs beyond HIV is a hot topic! The discussion should not become a reason to reduce PrEP access but instead should identify and encourage improved comprehensive sexual health services for prevention, identification and treatment of all STIs. A supportive and enabling discussion of STI risk and prevention should form part of PrEP provision.

The most recent systematic review confirmed that the STI rate was already high in people asking for PrEP, which is to be expected, and confirms that the people asking for PrEP are having condomless sex. Incidence of STIs is also high for people on PrEP. Whether this high incidence is due to changing sexual behaviour, or due to better detection of STIs because people are undergoing STI testing more regularly as part of a PrEP programme, is not yet resolved.

Either way, the take-home message is that the high rates of STIs that have been found among people using PrEP has identified an unmet need for STI prevention, diagnosis and treatment. In this way, the provision of PrEP is a door to the improvement of broader sexual health care and an opportunity to bring down the incidence of STIs. This is true across all populations using PrEP.

 

So, is PrEP a game-changer in the response to HIV? 

There is currently a lot of attention, funds, brainpower and physical effort going towards PrEP in many settings, including research into future delivery methods (injections or the vaginal ring, for example) that could increase PrEP choice, uptake and continuation. If these efforts are linked to an improvement in all HIV service provision (primary prevention, testing and treatment) and their integration with other health services, such as sexual health and mental health care, then PrEP could have a greater impact beyond prevention of individual HIV infections. However, it is unwise to sit back and think that PrEP will change the game on its own.

 

PrEP basics by Rosalind Coleman

PrEP success in London

Mr Gay England brings visibility to HIV stigma

06 September 2019

When Phillip Dzwonkiewicz won the Mr Gay England 2018 contest, he wanted to use his platform to talk about HIV. After years of struggling with his HIV-positive status, he no longer wanted to hide.

“I now live one life,” he said. “I live openly and it’s a massive weight off my shoulders.”

The next year, when competing in Mr Gay Europe 2018―he was runner up―he again used the platform to bring more visibility to HIV. “What still surprises me is how people tell me, “You don’t look like you have HIV”. It shows how misconceptions still exist,” he said.

As a dancer and performer, the Londoner-at-heart jumped at the opportunity to be the subject of a documentary. The film, Jus+ Like Me, features Mr Dzwonkiewicz coming to terms with his HIV status and how it affects his relationships with partners and his family. Since its launch, the film has won the European Cinematography Awards, the Queen Palm International film festival and was a semi-finalist at the London Independent Film Awards and ARFF Berlin International Awards.

“As a South African, I was aware of AIDS, but what struck me is how many people after seeing the film came forward to share their story about living with HIV,” Tom Falck, the Executive Producer of the film, said. He felt that Mr Dzwonkiewicz’s story had a lot of potential because his non-disclosure cost him a relationship; however, he respects the notion that some people choose not to reveal their HIV status. “Phil’s story is so inspirational, authentic and relatable,” he said.

The general response has been very positive, but the producers realized how stigma still exists.   “The hate messages on social media gave us 100% validation of what we sought to do,” Mr Falck said. “We cannot take a back seat; it’s important for all of us to fight the injustices and discrimination.”

In the film, Mr Dzwonkiewicz says that he hopes the documentary will help someone “just like me”. He and Mr Falck along with Director Samuel Douek started a campaign, #JUSTLIKEME, to keep the dialogue going and to raise further awareness. They hope it will encourage others to come forward and share their stories.

Mr Dzwonkiewicz explained that he has offered informal advice to friends for years but now is a peer support worker at Positive East, a nongovernmental organization focusing on HIV support services. “I want to do my little bit and help anyone any way I can,” he said. His peer work has opened his eyes to other communities.

“The demographics that I deal with are quite different than my social circle, but the journeys people describe resemble each other,” Mr Dzwonkiewicz said. He strongly believes in peer support and recalled how 56 Dean Street, the largest London sexual health National Health Service clinic, helped him along his entire journey from testing to treatment to understanding U = U (untransmittable = undetectable). Mr Dzwonkiewicz, like people who take antiretroviral therapy daily, can no longer transmit HIV because the virus is now undetectable in his blood.

“By being there with advice, support and counselling, I have gained such a quality of life,” he said, referring to 56 Dean Street.

“HIV doesn’t define me,” he said. “I am like any other person living my life to the fullest.”

Jus+ Like Me

Enter film site

15-minute version

Short version

Stigma makes HIV life-threatening

25 February 2019

“If I am meant to be a leader, I needed to be truthful,” said Lloyd Russell-Moyle, British Member of Parliament, reflecting on his bold move to reveal his HIV-positive status in the House of Commons in late November 2018, days before World AIDS Day.

He explained that for years he would honour people for their outstanding work in the HIV field and yet he never opened up and was honest with people about living with HIV.

“The more people don’t talk about it, the harder it is for everyone. As a Member of Parliament my job involves speaking out, being an advocate and helping people in their journey,” Mr Russell-Moyle said.

In his speech to the House of Commons, he described the sense of fear he had when he learned that he was living with HIV nearly 10 years ago. In his view, there is internal stigma, which kept him from speaking about his status for fear of “spreading” what used to be a deadly disease and the fear that people may reject him if they knew he was living with HIV.

“All that stigma makes a treatable disease life-threatening due to the impact on an individual’s mental health and access to medication,” he said in his emotional 28 November speech. In a telephone interview with UNAIDS, he specified that, “In no way should we glorify HIV, but it is liveable and manageable.” And living with HIV should not hold anyone back in any way, shape or form, he stated.

He desperately wants people to understand HIV better. “I want to get to the stage where I don’t have to explain that if you take one pill a day, you [have a viral load that is] undetectable and if you become undetectable you cannot pass the virus on to anyone,” he said. 

That’s why, with the leading British association representing professionals in HIV care, BHIVA, Mr Russell-Moyle wants to reform certain laws. One European Union law forbids people living with HIV from obtaining a full pilot licence.

“It’s outdated considering that HIV treatment now involves a pill a day with no side-effects,” he said.

He also has been vocal about the British Government’s public health spending cuts. “We are at a crossroads right now, having made so much progress,” Mr Russell-Moyle said. “We are in danger of lifting our foot off the pedal so close to the finish line.”

Not funding vaccine research and reducing sexual health screening and prevention will cost the government in the long run and ruin lives, he predicted. “It’s a race against the disease, and if we slow down at this stage we will likely see a rebound,” he said.

According to Public Health England, 12% of people living with HIV in England are unaware of their diagnosis. A Brighton-based foundation launched a Making HIV History campaign to improve knowledge and encourage people to come forward for testing—Mr Russell-Moyle noted that the Stigmasaurus video animations were a great tool to correct stereotypes.

“We have got the drugs, the tools to allow everyone to live happily, so for those who don’t know their status: get tested, get treatment, it will be okay.” He concluded, “It is okay.”

United Kingdom pledges to end HIV transmission in the country within 10 years

07 February 2019

The United Kingdom of Great Britain and Northern Ireland has announced that it will end the transmission of HIV in the country within 10 years—an announcement that was warmly welcomed by UNAIDS.

In 2016, all United Nations Member States pledged to end AIDS by 2030 in the United Nations Political Declaration on Ending AIDS. This recommitment from the United Kingdom is welcome news that the country remains determined to achieve that goal. 

The United Kingdom has dramatically stepped up its efforts to respond to HIV in recent years, resulting in a 28% decline in new HIV cases in the past two years alone. However, the government says it can do more.

The Secretary of State for Health and Social Care, Matt Hancock, launched the campaign, which is backed by an additional £600 000 from the Public Health England HIV Prevention Innovation Fund, at the AIDSfree Cities Global Forum in London on 30 January. The £600 000 will be used to support 14 volunteer organizations that are spearheading new approaches to HIV prevention and will focus on engaging at-risk or underserved communities.

Also at the event, the Secretary of State for International Development, Penny Mordaunt, made a bold declaration about the country’s commitment to ending AIDS globally. “While the world has made great strides in tackling HIV and AIDS, we need to step up our efforts,” she said. “We passionately believe we can create an AIDS-free future for the whole world. That’s the scale of our ambition.”

The United Kingdom Government has played a leading role in the global response to HIV since the start of the epidemic. It has invested £1.2 billion in the Global Fund to Fight AIDS, Tuberculosis and Malaria and is expanding access to antiretroviral therapy though UK Aid, a five-year, £150 million, programme set up to change the lives of more than 3 million of the world’s poorest people.

“This announcement is a further example of how committed the United Kingdom really is to ending AIDS. Not only in the United Kingdom, but around the world,” said Tim Martineau, Deputy Executive Director of UNAIDS, Programme, a.i. “UNAIDS has worked closely with the United Kingdom since 1996 and we look forward to continuing that partnership to ensure that every penny invested brings us one step closer to ending AIDS.”

The event in London was part of the AIDSfree Appeal, a campaign led by the Elton John AIDS Foundation and the London Evening Standard and Independent newspapers. The money raised from public donations through the appeal will be used to support Elton John AIDS Foundation projects in six key cities around the world—Atlanta, United States of America, Delhi, India, Kyiv, Ukraine, London, Maputo, Mozambique, and Nairobi, Kenya. Through UK Aid Match, the United Kingdom Government has pledged to double public donations up to £2 million, to be spent on projects in Maputo and Nairobi.

The AIDSfree Cities Global Forum welcomed leaders from the six cities, who spoke about their hopes for the future. The event was a prelude to the Fast-Track Cities Global Conference, taking place in London in September 2019, at which representatives of more than 275 Fast-Track cities will convene as the first global gathering of cities accelerating their work to end AIDS as a public health threat.

The Fast-Track cities initiative was launched by UNAIDS in 2014 in partnership with the City of Paris, the International Association of Providers of AIDS Care and UN-Habitat to provide support to cities to Fast-Track their HIV responses and end their AIDS epidemics by 2030.

London signed up to the Fast-Track cities initiative in 2018. New HIV infections in the city have fallen by more than 40% in recent years and London has surpassed the 90–90–90 targets—whereby 90% of people living with HIV know their HIV status, 90% of people who know their HIV-positive status are accessing treatment and 90% of people on treatment have suppressed viral loads—having already reached 95–98–97, a remarkable achievement.

“We are eager to take the lessons learned at the forum to a wider gathering of Fast-Track cities later this year in London that will take the measure of progress made and challenges still to be addressed,” said José M. Zuniga, President and Chief Executive Officer of the International Association of Providers of AIDS Care.

Ireland to support HIV services for the most vulnerable in the United Republic of Tanzania

14 December 2018

Ireland has pledged €400 000 to UNAIDS for a project to provide HIV services for the most vulnerable populations in the United Republic of Tanzania, with the first tranche, €200 000, already received.  

“Through our development programmes, Ireland supports the most marginalised in society to access key services so that they can live with dignity. Ireland is pleased to collaborate with UNAIDS to improve the plight of populations that are in most need of timely HIV services,” said the Irish Ambassador to the United Republic of Tanzania, Paul Sherlock.

UNAIDS will work in close collaboration with the Ministry of Health, the Benjamin Mkapa Foundation and civil society organizations to address issues that hinder the most vulnerable populations from accessing HIV prevention, treatment and care in a timely manner. Support that UNAIDS will provide includes convening stakeholders, providing technical leadership and strategic guidance and ensuring participation and representation.

Stigma and discrimination, inequality and violence against women and girls and criminal and punitive laws that affect vulnerable populations remain among the major barriers to an effective response to HIV in the country.

The 18-month project will help its beneficiaries with legal literary skills, raise awareness on the right to health and address HIV-related stigma and discrimination.

Ireland is a long-standing partner of UNAIDS, providing US$ 2.56 million in core funding to UNAIDS in 2018.

“UNAIDS and Ireland share a goal of ensuring that the AIDS response leaves no one behind. The funding from Ireland offers us a timely opportunity to give the most vulnerable populations in the United Republic of Tanzania a chance to live in dignity and good health,” said Leopold Zekeng, UNAIDS Country Director, United Republic of Tanzania.

Germany: taking a human-rights based approach to injecting drug use

16 October 2018

People who inject drugs often have one or more associated health issues. Drug use and mental health issues often coexist and drug use can increase the risk of contracting infections. Among people who inject drugs, for example, the risk of acquiring to HIV is 22 times greater than for people in the general population. People who use drugs are also widely stigmatized and marginalized, putting them out of reach of health and social services.

In line with Germany’s efforts to take a people-centred, human rights-based approach to health, the non-profit organization Fixpunkt has begun offering a safe haven for people who inject drugs. Fixpunkt provides a wide range of services, including support for people who are on opioid substitution therapy, counselling for mental health and social problems, basic health services, sterile injecting equipment and supervised drug consumption rooms and professional assistance in the event of overdose.

Controversial life-savers

For people who inject drugs, supervised drug consumption sites are a lifeline. They are also a critical entry point into the wider health and social support system. Currently, supervised drug consumption sites are available in six of the 15 federal states in Germany. The state of Baden-Württemberg, for example, has just decided to create the legal provisions to allow the facilities and the first supervised consumption room is about to be opened in the city of Karlsruhe.

However, in the nine other federal states legal barriers currently prevent the provision of these potentially life-saving services. “More political and financial support is needed to fulfil the real potential of safe injection sites. For people who use drugs, living on the streets, these are life-saving facilities. They often do not have access to medical, health and other social services. In these facilities they can establish contact and trust and find help to change their situation,” said Astrid Leicht, Director of Fixpunkt.

The Deputy Executive Director, a.i., of UNAIDS visited one of Fixpunkt’s mobile sites on 15 October to see the impact of the services they provide. “This is an important step forwards for Germany. By taking a people-centred approach and ensuring that people who inject drugs have access to harm reduction and other health services, such as safe injection sites, Berlin will be able to stop new HIV infections among people who inject drugs and reduce the harms related to injecting drug use. More projects like Fixpunkt are need to ensure that no one is left behind.” The biggest challenge, he learned, is that there are not enough facilities or resources to provide optimal opening hours or accompanying outreach work within the neighbourhoods and communities.

Sylvia Urban, board member of Aktionsbündnis gegen AIDS and of Deutsche AIDS-Hilfe, said, “The decisions in Baden-Württemberg and Karlsruhe are ground-breaking. We hope that the remaining states and many cities will follow. These facilities save lives and prevent HIV infections. From a public health and HIV prevention perspective, there is no good reason not to provide supervised drug consumption rooms.”

High demand in southern Germany and Bremen

Supervised drug-consumption rooms are desperately needed in, for example, Mannheim, the city with the highest number of drug-related deaths in proportion to inhabitants, as well as in Stuttgart, Munich, Nuremberg, Augsburg and Bremen, which have high numbers of preventable drug-related deaths.

Worrying situation in eastern Europe

UNAIDS and the World Health Organization recognize that supervised drug consumption facilities are a particularly important intervention. Yet, in eastern Europe there are very few facilities of this kind and in some countries, including the Russian Federation, there are virtually no harm reduction services provided at all amid a context of rising new HIV infections.

“Supervised drug-consumption facilities and harm reduction programmes are crucial components of HIV and hepatitis prevention. The tools and interventions to end the epidemics are all available, but many governments prevent their implementation,” said Sylvia Urban, from Deutsche AIDS Hilfe. “Only with services to minimize the negative health impacts of drug use can the HIV epidemic be stopped. In order to achieve this, legal and other barriers, including stigma, need to be removed.”

More Portuguese cities commit to the Fast-Track

12 October 2018

On 10 October, the mayors of the Portuguese cities of Almada, Amadora, Loures, Odivelas, Oeiras, Portimão and Sintra signed the Paris Declaration to end the AIDS epidemic in cities. Joining Cascais, Lisbon and Oporto, 10 Portuguese cities have now signed the declaration. In signing the Paris Declaration, mayors commit to putting their cities on the Fast-Track to ending the AIDS epidemic. 

Portugal has been a pioneer in the AIDS response since the outset of the epidemic, creating enabling legal environments, enacting progressive drug policies and making HIV treatment free for all, regardless of their migration status. Portugal continues to lead today, driving community-based care models and promoting better integration of health-care services.

During a site visit in Cascais, Portugal, Tim Martineau, UNAIDS Deputy Executive Director, a.i., saw the nationwide launch of an initiative that aims to bring HIV services closer to the people who need them: HIV testing in community pharmacies. This initiative was integrated into the Cascais Fast-Track City Strategy. Self-testing is set to become available later this year, since the necessary legislation was just approved by the Portuguese Government

During his trip to Portugal, Mr Martineau also visited the Mobile Outreach Program of Aires do Pinhal – Association for Social Inclusion. With the support of the Ministry of Health, since 1986 the programme has provided harm reduction and social support services to people who inject drugs, giving access to services to about 1200 people daily. Services—including screening and treatment for HIV, hepatitis C, tuberculosis and syphilis, as well as methadone delivery, syringe exchange and distribution of condoms—are provided free from discrimination to people regardless of their nationality, including undocumented migrants.

The signing ceremony for the Paris Declaration was held at the Pálacio de São Bento in Lisbon, Portugal, and was attended by the Director-General of Health, Graça Freitas, Mr Martineau and representatives of civil society. In his closing speech, the Secretary of State, Fernando Araújo, expressed his hope that Portugal would continue to show leadership in the Fast-Track response to HIV.

Pages